Originator Organization NiKang Therapeutics, Inc.Startup |
Active Organization NiKang Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | NiKang Therapeutics, Inc.Startup | 10 Sep 2024 |